Item Number | Policy/Procedure | Date Posted | Comment Period Closed | Status | Document Links |
---|---|---|---|---|---|
2023-LHCC-329 | Adverse Determinations | 12/27/23 | 2/10/24 | Approved | Adverse Determinations |
2023-UHC-510 | Collagen Crosslinks and Biochemical Markers of Bone Turnover | 12/21/23 | 2/4/24 | Approved | Collagen Crosslinks and Biochemical Markers of Bone Turnover |
2023-UHC-781 | Deep Brain Cortical Stimulation | 12/21/23 | 2/4/24 | Approved | Deep Brain Cortical Stimulation |
2023-UHC-782 | Discogenic Pain Treatment | 12/21/23 | 2/4/24 | Approved | Discogenic Pain Treatment |
2023-UHC-948 | Catheter Ablation for Atrial Fibrillation | 12/21/23 | 2/4/24 | Approved | Catheter Ablation for Atrial Fibrillation |
2023-HBL-1061 | Venous Angio w or w/out Stent Placement or Venous Stent Alone | 12/21/23 | 2/4/24 | Approved | Venous Angio w or w/out Stent Placement or Venous Stent Alone |
2023-ACLA-1954 | Cochlear Implants | 12/21/23 | 2/4/24 | Approved | Cochlear Implants |
2023-UHC-2275 | ID and Strat of Mbrs for CM | 12/21/23 | 2/4/24 | Approved | ID and Strat of Mbrs for CM |
2023-HBL-2284 | Septoplasty | 12/21/23 | 2/4/24 | Approved | Septoplasty |
2023-HUM-2286 | Code Removal – VADs | 12/21/23 | 2/4/24 | Completed | Code Removal – VADs |
2023-HUM-2287 | Code Removal – Transplant | 12/21/23 | 2/4/24 | Completed | Code Removal – Transplant |
2023-LHCC-2282 | Provider Preventable Conditions | 12/21/23 | 2/4/24 | Approved | Provider Preventable Conditions |
2023-LHCC-1515 | Temporary Limited Authorization Reviews | 12/21/23 | 2/4/24 | Completed | Temporary Limited Authorization Reviews |
2023-LDH-17 | MCO Manual > Part 4: Services > In Lieu of Services > Physical Health Services > Outpatient Lactation Support (Proposed effective date = 1/1/2024) | 12/8/23 | 1/22/24 | Pending | Outpatient Lactation Support |
2023-UHC-201 | Aphersis | 12/7/23 | 1/21/24 | Approved | Aphersis |
2023-UHC-205 | Computed Tomographic Colonography | 12/7/23 | 1/21/24 | Approved | Computed Tomographic Colonography |
2023-UHC-218 | Pharmacogenetic Testing | 12/7/23 | 1/21/24 | Approved | Pharmacogenetic Testing |
2023-UHC-223 | Vagus and External Trigeminal Nerve Stimulation | 12/7/23 | 1/21/24 | Approved | Vagus and External Trigeminal Nerve Stimulation |
2023-UHC-224 | Visual Information Processing Evaluation and Orthoptic and Vision Therapy | 12/7/23 | 1/21/24 | Approved | Visual Information Processing Evaluation and Orthoptic and Vision Therapy |
2023-UHC-248 | Vertebral Tethering for Scoliosis | 12/7/23 | 1/21/24 | Approved | Vertebral Tethering for Scoliosis |
2023-UHC-310 | Total Artificial Disc Replacement Spine – Revised | 12/7/23 | 1/21/24 | Approved | Total Artificial Disc Replacement Spine – Revised |
2023-UHC-478 | Obstructive and Central Sleep Apnea Treatment | 12/7/23 | 1/21/24 | Approved | Obstructive and Central Sleep Apnea Treatment |
2023-UHC-486 | Abnormal Uterine Bleeding and Uterine Fibroids | 12/7/23 | 1/21/24 | Approved | Abnormal Uterine Bleeding and Uterine Fibroids |
2023-UHC-791 | Neurophysiologic Testing | 12/7/23 | 1/21/24 | Approved | Neurophysiologic Testing |
2023-UHC-1063 | Temporomandibular Joint Disorder | 12/7/23 | 1/21/24 | Approved | Temporomandibular Joint Disorder |
2023-LHCC-1217 | Ultrasound in Pregnancy | 12/7/23 | 1/21/24 | Approved | Ultrasound in Pregnancy |
2023-LHCC-1273 | Orthognathic Surgery | 12/7/23 | 1/21/24 | Approved | Orthognathic Surgery |
2023-LHCC-1277 | Panniculectomy | 12/7/23 | 1/21/24 | Approved | Panniculectomy |
2023-LHCC-1361 | Pediatric Heart Transplant | 12/7/23 | 1/21/24 | Approved | Pediatric Heart Transplant |
2023-UHC-1461 | Unicondylar Spacer Devices for Treatment of Pain or Disability | 12/7/23 | 1/21/24 | Approved | Unicondylar Spacer Devices for Treatment of Pain or Disability |
2023-LHCC-1710 | Maternal Child Health Program Description | 12/7/23 | 1/21/24 | Completed | Maternal Child Health Program Description |
2023-LHCC-1741 | AHCT for Sickle Cell Anemia and Thalassemia | 12/7/23 | 1/21/24 | Approved | AHCT for Sickle Cell Anemia and Thalassemia |
2023-LHCC-1742 | Ferriscan R2 MRI | 12/7/23 | 1/21/24 | Approved | Ferriscan R2 MRI |
2023-LHCC-1744 | Phototherapy for Neonatal Hyperbilirubinemia | 12/7/23 | 1/21/24 | Approved | Phototherapy for Neonatal Hyperbilirubinemia |
2023-LHCC-1745 | Donor Lymphocyte Infusion | 12/7/23 | 1/21/24 | Approved | Donor Lymphocyte Infusion |
2023-UHC-1760 | Radiation Therapy | 12/7/23 | 1/21/24 | Approved | Radiation Therapy |
2023-UHC-1762 | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery | 12/7/23 | 1/21/24 | Approved | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery |
2023-LHCC-1834 | Enteral Nutrition | 12/7/23 | 1/21/24 | Approved | Enteral Nutrition |
2023-LHCC-1842 | Cosmetic and Reconstructive Procedures | 12/7/23 | 1/21/24 | Approved | Cosmetic and Reconstructive Procedures |
2023-ACLA-2276 | Level 3.7 Adolescent CCP.4047 | 12/7/23 | 1/21/24 | Approved | Level 3.7 Adolescent CCP.4047 |
2023-LHCC-140 | Timeliness of UM Decisions | 11/20/23 | 1/4/24 | Approved | Timeliness of UM Decisions |
2023-UHC-483 | Genetic Testing for Hereditary Cancer | 11/20/23 | 1/4/24 | Approved | Genetic Testing for Hereditary Cancer |
2023-LHCC-502 | Clinical Information and Documentation Policy | 11/20/23 | 1/4/24 | Approved | Clinical Information and Documentation Policy |
2023-LHCC-694 | Record Keeping and Documentation Standards | 11/20/23 | 1/4/24 | Approved | Record Keeping and Documentation Standards |
2023-ABH-822 | ABH Provider Manual | 11/20/23 | 1/4/24 | Approved | ABH Provider Manual |
2023-HBL-1060 | Level of Care - Specialty Pharmaceuticals | 11/20/23 | 1/4/24 | Approved | Level of Care - Specialty Pharmaceuticals |
2023-HBL-1149 | Colonoscopy | 11/20/23 | 1/4/24 | Approved | Colonoscopy |
2023-ACLA-1442 | ACLA Prior Authorization Service List | 11/20/23 | 1/4/24 | Completed | ACLA Prior Authorization Service List |
2023-LHCC-1478 | Visits on Same Day as Surgery | 11/20/23 | 1/4/24 | Approved | Visits on Same Day as Surgery |
2023-LHCC-1480 | Pre-operative Visits | 11/20/23 | 1/4/24 | Approved | Pre-operative Visits |
2023-LHCC-1481 | Outpatient Consultation | 11/20/23 | 1/4/24 | Approved | Outpatient Consultation |
2023-LHCC-1485 | Unbundled Surgical Procedures | 11/20/23 | 1/4/24 | Approved | Unbundled Surgical Procedures |
2023-LHCC-1486 | Post-operative Visits | 11/20/23 | 1/4/24 | Approved | Post-operative Visits |
2023-LHCC-1488 | Unbundled Professional Services | 11/20/23 | 1/4/24 | Approved | Unbundled Professional Services |
2023-LHCC-1513 | Continuity and Coordination of Services | 11/20/23 | 1/4/24 | Approved | Continuity and Coordination of Services |
2023-HBL-2258 | Claims Sub-Professional | 11/20/23 | 1/4/24 | Approved | Claims Sub-Professional |
2023-HBL-2259 | Gender Affirming Prior Authorization Changes | 11/20/23 | 1/4/24 | Completed | Gender Affirming Prior Authorization Changes |
2023-HBL-2270 | Provider and Member Bill of Rights | 11/20/23 | 1/4/24 | Approved | Provider and Member Bill of Rights |
2023-HBL-2271 | Provider Network and Management | 11/20/23 | 1/4/24 | Approved | Provider Network and Management |
2023-HUM-1826 | Revenue Codes for Outpatient Services | 12/21/23 | 2/4/24 | Denied | Revenue Codes for Outpatient Services |
2023-LHCC-1111 | Thyroid Insulin Test in Ped | 11/9/23 | 12/24/23 | Approved | Thyroid Insulin Test in Ped |
2023-LHCC-1112 | Digital EEG Analysis | 11/9/23 | 12/24/23 | Approved | Digital EEG Analysis |
2023-LHCC-1113 | Cardiac Biomarker Testing | 11/9/23 | 12/24/23 | Approved | Cardiac Biomarker Testing |
2023-LHCC-1115 | Vitamin D Testing in Peds | 11/9/23 | 12/24/23 | Approved | Vitamin D Testing in Peds |
2023-LHCC-1168 | Allergy Testing & Therapy | 11/9/23 | 12/24/23 | Approved | Allergy Testing & Therapy |
2023-HBL-1197 | Angiographic Evaluation and Endovascular Intervention for Dialysis Access Circuit Dysfunction | 11/9/23 | 12/24/23 | Approved | Angiographic Evaluation and Endovascular Intervention for Dialysis Access Circuit Dysfunction |
2023-HBL-1249 | Penile Prosthesis Implantation | 11/9/23 | 12/24/23 | Approved | Penile Prosthesis Implantation |
2023-LHCC-1278 | Evoked Potential Testing | 11/9/23 | 12/24/23 | Approved | Evoked Potential Testing |
2023-LHCC-1279 | Measure Serum 1.25 Vit D | 11/9/23 | 12/24/23 | Approved | Measure Serum 1.25 Vit D |
2023-LHCC-1280 | EEG headache | 11/9/23 | 12/24/23 | Approved | EEG headache |
2023-LHCC-1359 | Testing for Select Genitourinary Conditions | 11/9/23 | 12/24/23 | Approved | Testing for Select Genitourinary Conditions |
2023-LHCC-1386 | Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins | 11/9/23 | 12/24/23 | Approved | Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins |
2023-LHCC-1417 | Adult Crisis Stabilization | 11/9/23 | 12/24/23 | Approved | Adult Crisis Stabilization |
2023-HBL-1431 | Cryosurgical, Radiofrequency or Laser Ablation to Treat Solid Tumors Outside the Liver | 11/9/23 | 12/24/23 | Approved | Cryosurgical, Radiofrequency or Laser Ablation to Treat Solid Tumors Outside the Liver |
2023-LHCC-1702 | Holter Monitor | 11/9/23 | 12/24/23 | Approved | Holter Monitor |
2023-LHCC-1704 | Helicobacter Pylori Serology Testing | 11/9/23 | 12/24/23 | Approved | Helicobacter Pylori Serology Testing |
2023-LHCC-1706 | Wireless Motility Capsule | 11/9/23 | 12/24/23 | Approved | Wireless Motility Capsule |
2023-UHC-1733 | Coordination, Continuity and Transition of Behavioral Health Care | 11/9/23 | 12/24/23 | Approved | Coordination, Continuity and Transition of Behavioral Health Care |
2023-UHC-2250 | Device and Skin Substitute Policy | 11/9/23 | 12/24/23 | Approved | Device and Skin Substitute Policy |
2023-HBL-2264 | Moderate to Deep Anesthesia Services for Dental Surgery in the Facility Setting | 11/9/23 | 12/24/23 | Approved | Moderate to Deep Anesthesia Services for Dental Surgery in the Facility Setting |
2023-LHCC-2269 | Concert Genetics Hereditary Cancer Susceptibility | 11/9/23 | 12/24/23 | Pending | Concert Genetics Hereditary Cancer Susceptibility |
2023-HBL-258 | Health Care Management Denial | 11/1/23 | 12/16/23 | Approved | Health Care Management Denial |
2023-LHCC-336 | Care Management Program Description | 11/1/23 | 12/16/23 | Approved | Care Management Program Description |
2023-UHC-579 | Surgery of the Hip | 11/1/23 | 12/16/23 | Approved | Surgery of the Hip |
2023-UHC-789 | Minimally Invasive Procedures for Gastric and Esophageal Diseases | 11/1/23 | 12/16/23 | Approved | Minimally Invasive Procedures for Gastric and Esophageal Diseases |
2023-UHC-827 | Prolotherapy and Platelet Rich Plasma Therapies | 11/1/23 | 12/16/23 | Approved | Prolotherapy and Platelet Rich Plasma Therapies |
2023-LHCC-896 | Physician Incentive Plan | 11/1/23 | 12/16/23 | Approved | Physician Incentive Plan |
2023-UHC-1589 | Surgical Treatment of Lymphedema | 11/1/23 | 12/16/23 | Approved | Surgical Treatment of Lymphedema |
2023-UHC-1719 | Louisiana BH Supplemental Clinical Care | 11/1/23 | 12/16/23 | Approved | Louisiana BH Supplemental Clinical Care |
2023-UHC-1785 | Plagiocephaly and Craniosynostosis Treatment | 11/1/23 | 12/16/23 | Approved | Plagiocephaly and Craniosynostosis Treatment |
2023-UHC-2260 | Mobility Devices, Options and Accessories | 11/1/23 | 12/16/23 | Approved | Mobility Devices, Options and Accessories |
2023-UHC-443 | Ambulance Services | 11/9/23 | 12/24/23 | Denied | Ambulance Services |
2023-LDH-16 | MCO Manual > Part 4: Services > Professional Services > Tobacco Cessation Counseling Services (Effective date = 6/20/2023) | 10/26/23 | 12/10/23 | Pending | Tobacco Cessation Counseling Services |
2023-ABH-1007 | BH Provider Monitoring Strategy | 10/24/23 | 12/8/23 | Approved | BH Provider Monitoring Strategy |
2023-LHCC-1477 | Duplicate Primary Code Billing | 10/23/23 | 12/7/23 | Approved | Duplicate Primary Code Billing |
2023-LHCC-1484 | Status B Bundled Services | 10/23/23 | 12/7/23 | Approved | Status B Bundled Services |
2023-LHCC-1492 | New Patient | 10/23/23 | 12/7/23 | Approved | New Patient |
2023-HBL-1717 | Utilization Management | 10/23/23 | 12/7/23 | Completed | Utilization Management |
2023-UHC-1737 | Computer-Assisted Surgical Navigation for Musculoskeletal Procedures | 10/23/23 | 12/7/23 | Approved | Computer-Assisted Surgical Navigation for Musculoskeletal Procedures |
2023-LHCC-1752 | Epidural Spine Injections | 10/23/23 | 12/7/23 | Approved | Epidural Spine Injections |
2023-LHCC-1880 | Hip Arthroplasty | 10/23/23 | 12/7/23 | Approved | Hip Arthroplasty |
2023-LHCC-1881 | Hip Arthroscopy | 10/23/23 | 12/7/23 | Approved | Hip Arthroscopy |
2023-LHCC-1960 | Dually Diagnosed Continuous Improvement | 10/23/23 | 12/7/23 | Approved | Dually Diagnosed Continuous Improvement |
2023-HUM-2212 | 80305, 80306, 80307 Limit Reimbursement for Presumptive Drug Testing to 24 per Year | 10/23/23 | 12/7/23 | Approved | 80305, 80306, 80307 Limit Reimbursement for Presumptive Drug Testing to 24 per Year |
2023-UHC-2252 | Hospital Services: Observation and Inpatient | 10/23/23 | 12/7/23 | Approved | Hospital Services: Observation and Inpatient |
2023-ABH-2253 | Utilization Management Timeliness Standards and Decision Notification Amendment | 10/23/23 | 12/7/23 | Completed | Utilization Management Timeliness Standards and Decision Notification Amendment |
2023-ABH-2254 | Benefit Exception Amendment | 10/23/23 | 12/7/23 | Completed | Benefit Exception Amendment |
2023-ABH-2255 | Decision Making Criteria Notification Amendment | 10/23/23 | 12/7/23 | Completed | Decision Making Criteria Notification Amendment |
2023-HBL-2223 | Provider Quality Monitoring Strategy | 10/23/23 | 12/7/23 | Approved | Provider Quality Monitoring Strategy |
2023-UHC-206 | Electric Tumor Treatment Field Therapy | 10/23/23 | 12/7/23 | Approved | Electric Tumor Treatment Field Therapy |
2023-UHC-378 | Surgery of the Shoulder | 10/23/23 | 12/7/23 | Approved | Surgery of the Shoulder |
2023-UHC-474 | Rhinoplasty and Other Nasal Procedures | 10/23/23 | 12/7/23 | Approved | Rhinoplasty and Other Nasal Procedures |
2023-LHCC-682 | Active Procedures in Physical Medicine | 10/23/23 | 12/7/23 | Approved | Active Procedures in Physical Medicine |
2023-LHCC-685 | Experimental, Unproven, or Investigational Services | 10/23/23 | 12/7/23 | Approved | Experimental, Unproven, or Investigational Services |
2023-LHCC-732 | Heart (cardiac) PET | 10/23/23 | 12/7/23 | Approved | Heart (cardiac) PET |
2023-LHCC-770 | Fractional Flow Reserve CT | 10/23/23 | 12/7/23 | Approved | Fractional Flow Reserve CT |
2023-LHCC-776 | Transeophageal (TEE) Echo | 10/23/23 | 12/7/23 | Approved | Transeophageal (TEE) Echo |
2023-UHC-780 | Core Decompression Avascular Necrosis | 10/23/23 | 12/7/23 | Approved | Core Decompression Avascular Necrosis |
2023-UHC-787 | Lithotripsy Salivary Stones | 10/23/23 | 12/7/23 | Approved | Lithotripsy Salivary Stones |
2023-UHC-793 | Virtual Upper Gastrointestinal Endoscopy | 10/23/23 | 12/7/23 | Approved | Virtual Upper Gastrointestinal Endoscopy |
2023-UHC-826 | Surgery of the Elbow | 10/23/23 | 12/7/23 | Approved | Surgery of the Elbow |
2023-UHC-1122 | Percutaneous Vertebroplasty and Kyphoplasty | 10/23/23 | 12/7/23 | Approved | Percutaneous Vertebroplasty and Kyphoplasty |
2023-LHCC-1167 | DME Clinical Policy | 10/23/23 | 12/7/23 | Approved | DME Clinical Policy |
2023-LHCC-1268 | Bone-Anchored Hearing Aid | 10/23/23 | 12/7/23 | Approved | Bone-Anchored Hearing Aid |
2023-UHC-1404 | Breast Imaging for Screening and Diagnosing Cancer | 10/23/23 | 12/7/23 | Approved | Breast Imaging for Screening and Diagnosing Cancer |
2023-UHC-1418 | Autologous Cellular Therapy | 10/23/23 | 12/7/23 | Approved | Autologous Cellular Therapy |
2023-UHC-1424 | Intraoperative Hyperthermic Intraperitoneal Chemotherapy | 10/23/23 | 12/7/23 | Approved | Intraoperative Hyperthermic Intraperitoneal Chemotherapy |
2023-UHC-1458 | Hepatitis Screening | 10/23/23 | 12/7/23 | Approved | Hepatitis Screening |
2023-LHCC-1476 | Status P Bundled Service | 10/23/23 | 12/7/23 | Approved | Status P Bundled Service |
2023-LDH-15 | MCO Manual > Part 4: Services > Pharmacy > Behavioral Health Specific Pharmacy Policies and Procedures (Proposed effective date = 12/1/2023) | 10/18/23 | 12/2/23 | Completed | Behavioral Health Specific Pharmacy Policies and Procedures |
2023-ACLA-873 | CT Bone Density Study | 10/18/23 | 12/2/23 | Approved | CT Bone Density Study |
2023-ACLA-874 | CT (Virtual) Colonoscopy | 10/18/23 | 12/2/23 | Approved | CT (Virtual) Colonoscopy |
2023-ACLA-875 | Chest (Thorax) CT | 10/18/23 | 12/2/23 | Approved | Chest (Thorax) CT |
2023-ACLA-876 | Chest CTA | 10/18/23 | 12/2/23 | Approved | Chest CTA |
2023-ACLA-877 | Chest MRA | 10/18/23 | 12/2/23 | Approved | Chest MRA |
2023-ACLA-878 | Chest (Thorax) MRI | 10/18/23 | 12/2/23 | Approved | Chest (Thorax) MRI |
2023-ACLA-879 | Brain (Head) MRS | 10/18/23 | 12/2/23 | Approved | Brain (Head) MRS |
2023-ACLA-880 | Cervical Spine MRI | 10/18/23 | 12/2/23 | Approved | Cervical Spine MRI |
2023-ACLA-881 | Cervical Spine CT | 10/18/23 | 12/2/23 | Approved | Cervical Spine CT |
2023-ACLA-882 | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) | 10/18/23 | 12/2/23 | Approved | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) |
2023-ACLA-884 | Brain (Head) MRA/MRV | 10/18/23 | 12/2/23 | Approved | Brain (Head) MRA/MRV |
2023-ACLA-887 | CTA Aortogram with Runoff | 10/18/23 | 12/2/23 | Approved | CTA Aortogram with Runoff |
2023-ACLA-1147 | Brain PET Scan | 10/18/23 | 12/2/23 | Approved | Brain PET Scan |
2023-ACLA-1148 | Unlisted Studies | 10/18/23 | 12/2/23 | Approved | Unlisted Studies |
2023-ACLA-1448 | Pet Scans | 10/18/23 | 12/2/23 | Approved | Pet Scans |
2023-ACLA-2249 | Tumor Imaging PET-Any Site (Unlisted PET) | 10/18/23 | 12/2/23 | Approved | Tumor Imaging PET-Any Site (Unlisted PET) |
2023-ACLA-852 | Heart (Cardiac) PET with CT for Attenuation | 10/17/23 | 12/1/23 | Approved | Heart (Cardiac) PET with CT for Attenuation |
2023-ACLA-853 | Heart MRI | 10/17/23 | 12/1/23 | Approved | Heart MRI |
2023-ACLA-854 | Electron-Beam Tomography (EBCT) or Non-Contrast Coronary Computed Tomography (Non-contrast CCT) | 10/17/23 | 12/1/23 | Approved | Electron-Beam Tomography (EBCT) or Non-Contrast Coronary Computed Tomography (Non-contrast CCT) |
2023-ACLA-855 | Heart (cardiac) PET | 10/17/23 | 12/1/23 | Approved | Heart (cardiac) PET |
2023-ACLA-856 | Functional Brain MRI | 10/17/23 | 12/1/23 | Approved | Functional Brain MRI |
2023-ACLA-857 | CT Heart, CT Heart Congenital (Not including coronary arteries) | 10/17/23 | 12/1/23 | Approved | CT Heart, CT Heart Congenital (Not including coronary arteries) |
2023-ACLA-858 | Upper Extremity MRA/MRV | 10/17/23 | 12/1/23 | Approved | Upper Extremity MRA/MRV |
2023-ACLA-859 | Upper Extremity MRI | 10/17/23 | 12/1/23 | Approved | Upper Extremity MRI |
2023-ACLA-861 | Breast MRI | 10/17/23 | 12/1/23 | Approved | Breast MRI |
2023-ACLA-862 | Upper Extremity CT | 10/17/23 | 12/1/23 | Approved | Upper Extremity CT |
2023-ACLA-863 | Thoracic Spine MRI | 10/17/23 | 12/1/23 | Approved | Thoracic Spine MRI |
2023-ACLA-864 | Lower Extremity CTA/CTV | 10/17/23 | 12/1/23 | Approved | Lower Extremity CTA/CTV |
2023-ACLA-865 | Upper Extremity CTA/CTV | 10/17/23 | 12/1/23 | Approved | Upper Extremity CTA/CTV |
2023-ACLA-866 | Thoracic Spine CT | 10/17/23 | 12/1/23 | Approved | Thoracic Spine CT |
2023-ACLA-867 | Temporomandibular Joint (TMJ) MRI | 10/17/23 | 12/1/23 | Approved | Temporomandibular Joint (TMJ) MRI |
2023-ACLA-868 | Spinal Canal MRA | 10/17/23 | 12/1/23 | Approved | Spinal Canal MRA |
2023-ACLA-869 | Sinus & Maxillofacial CT Limited or Localized Follow Up Sinus CT | 10/17/23 | 12/1/23 | Approved | Sinus & Maxillofacial CT Limited or Localized Follow Up Sinus CT |
2023-ACLA-870 | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT | 10/17/23 | 12/1/23 | Approved | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT |
2023-ACLA-871 | Sinus Face Orbit MRI | 10/17/23 | 12/1/23 | Approved | Sinus Face Orbit MRI |
2023-ACLA-872 | CT Coronary Angiography (CCTA) | 10/17/23 | 12/1/23 | Approved | CT Coronary Angiography (CCTA) |
2023-LHCC-687 | Measurable Progressive Improvement | 10/17/23 | 12/1/23 | Approved | Measurable Progressive Improvement |
2023-LHCC-689 | Outpatient Habilitative PT and OT Therapy | 10/17/23 | 12/1/23 | Approved | Outpatient Habilitative PT and OT Therapy |
2023-LHCC-690 | Outpatient Habilitative and Rehabilitative Speech Therapy | 10/17/23 | 12/1/23 | Approved | Outpatient Habilitative and Rehabilitative Speech Therapy |
2023-LHCC-691 | Passive Treatment | 10/17/23 | 12/1/23 | Approved | Passive Treatment |
2023-ACLA-836 | Pelvis MRI | 10/17/23 | 12/1/23 | Approved | Pelvis MRI |
2023-ACLA-837 | Pelvis MRA | 10/17/23 | 12/1/23 | Approved | Pelvis MRA |
2023-ACLA-838 | Pelvis CT Angiography | 10/17/23 | 12/1/23 | Approved | Pelvis CT Angiography |
2023-ACLA-839 | Pelvis CT | 10/17/23 | 12/1/23 | Approved | Pelvis CT |
2023-ACLA-840 | Neck MRA/MRV | 10/17/23 | 12/1/23 | Approved | Neck MRA/MRV |
2023-ACLA-841 | Neck CTA | 10/17/23 | 12/1/23 | Approved | Neck CTA |
2023-ACLA-842 | MUGA (Multiple Gated Acquisition) Scan | 10/17/23 | 12/1/23 | Approved | MUGA (Multiple Gated Acquisition) Scan |
2023-ACLA-843 | Neck CT | 10/17/23 | 12/1/23 | Approved | Neck CT |
2023-ACLA-844 | Low Field MRI | 10/17/23 | 12/1/23 | Approved | Low Field MRI |
2023-ACLA-845 | MPI - Myocardial Perfusion Imaging | 10/17/23 | 12/1/23 | Approved | MPI - Myocardial Perfusion Imaging |
2023-ACLA-846 | Lumbar Spine CT | 10/17/23 | 12/1/23 | Approved | Lumbar Spine CT |
2023-ACLA-847 | Lumbar Spine MRI | 10/17/23 | 12/1/23 | Approved | Lumbar Spine MRI |
2023-ACLA-848 | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) | 10/17/23 | 12/1/23 | Approved | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) |
2023-ACLA-849 | Lower Extremity MRA/MRV | 10/17/23 | 12/1/23 | Approved | Lower Extremity MRA/MRV |
2023-ACLA-850 | Lower Extremity CT | 10/17/23 | 12/1/23 | Approved | Lower Extremity CT |
2023-ACLA-851 | Low Dose CT for Lung Cancer Screening | 10/17/23 | 12/1/23 | Approved | Low Dose CT for Lung Cancer Screening |
2023-LHCC-769 | Cardiac Resynchronization Therapy (CRT) | 10/16/23 | 11/30/23 | Approved | Cardiac Resynchronization Therapy (CRT) |
2023-LHCC-771 | Heart Catheterization | 10/16/23 | 11/30/23 | Approved | Heart Catheterization |
2023-LHCC-775 | Stress Echocardiography | 10/16/23 | 11/30/23 | Approved | Stress Echocardiography |
2023-LHCC-778 | Transthoracic (TTE) Echo | 10/16/23 | 11/30/23 | Approved | Transthoracic (TTE) Echo |
2023-ACLA-883 | Brain {Head} CT | 10/16/23 | 11/30/23 | Approved | Brain {Head} CT |
2023-ACLA-885 | Brain (Head) CTA | 10/16/23 | 11/30/23 | Approved | Brain (Head) CTA |
2023-ACLA-886 | Bone Marrow MRI | 10/16/23 | 11/30/23 | Approved | Bone Marrow MRI |
2023-ACLA-888 | Abdomen/Pelvis CTA Combo | 10/16/23 | 11/30/23 | Approved | Abdomen/Pelvis CTA Combo |
2023-ACLA-889 | Abdomen MRA (Angiography} | 10/16/23 | 11/30/23 | Approved | Abdomen MRA (Angiography} |
2023-ACLA-890 | Abdomen/Pelvis CT Combo | 10/16/23 | 11/30/23 | Approved | Abdomen/Pelvis CT Combo |
2023-ACLA-891 | Abdomen MRI, MRCP | 10/16/23 | 11/30/23 | Approved | Abdomen MRI, MRCP |
2023-ACLA-892 | Abdomen CT | 10/16/23 | 11/30/23 | Approved | Abdomen CT |
2023-ACLA-893 | Abdomen CT Angiography | 10/16/23 | 11/30/23 | Approved | Abdomen CT Angiography |
2023-LHCC-1429 | Heart PET with CT Attenuation | 10/16/23 | 11/30/23 | Approved | Heart PET with CT Attenuation |
2023-LHCC-1711 | Sympathetic Nerve Block | 10/16/23 | 11/30/23 | Approved | Sympathetic Nerve Block |
2023-LHCC-1750 | Sacroiliac Joint Injections-NIA | 10/16/23 | 11/30/23 | Approved | Sacroiliac Joint Injections-NIA |
2023-LHCC-1751 | Spinal Cord Stimulation-NIA | 10/16/23 | 11/30/23 | Approved | Spinal Cord Stimulation-NIA |
2023-LHCC-1756 | Facet Joint Denervation | 10/16/23 | 11/30/23 | Approved | Facet Joint Denervation |
2023-LHCC-1764 | Single Photon Emission Computed Tomography SPECT | 10/16/23 | 11/30/23 | Approved | Single Photon Emission Computed Tomography SPECT |
2023-HBL-2158 | Human Chorionic Gonadotrophin Testing | 10/16/23 | 11/30/23 | Approved | Human Chorionic Gonadotrophin Testing |
2023-LHCC-745 | Neck CT (soft tissue) | 10/16/23 | 11/30/23 | Approved | Neck CT (soft tissue) |
2023-LHCC-746 | Neck CTA | 10/16/23 | 11/30/23 | Approved | Neck CTA |
2023-LHCC-747 | Neck MRA/MRV | 10/16/23 | 11/30/23 | Approved | Neck MRA/MRV |
2023-LHCC-748 | Oncology PET Scans | 10/16/23 | 11/30/23 | Approved | Oncology PET Scans |
2023-LHCC-749 | Pelvis CT | 10/16/23 | 11/30/23 | Approved | Pelvis CT |
2023-LHCC-750 | Pelvis CT Angiography | 10/16/23 | 11/30/23 | Approved | Pelvis CT Angiography |
2023-LHCC-751 | Pelvis MRA | 10/16/23 | 11/30/23 | Approved | Pelvis MRA |
2023-LHCC-752 | Pelvis MRI | 10/16/23 | 11/30/23 | Approved | Pelvis MRI |
2023-LHCC-753 | Orbit, Face, Neck, Sinus MRI | 10/16/23 | 11/30/23 | Approved | Orbit, Face, Neck, Sinus MRI |
2023-LHCC-754 | Sinus & Maxillofacial CT limited or localized f/u Sinus CT | 10/16/23 | 11/30/23 | Approved | Sinus & Maxillofacial CT limited or localized f/u Sinus CT |
2023-LHCC-755 | Spinal Canal MRA | 10/16/23 | 11/30/23 | Approved | Spinal Canal MRA |
2023-LHCC-756 | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT | 10/16/23 | 11/30/23 | Approved | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT |
2023-LHCC-757 | Temporomandibular Joint (TMJ) MRI | 10/16/23 | 11/30/23 | Approved | Temporomandibular Joint (TMJ) MRI |
2023-LHCC-758 | Thoracic Spine CT | 10/16/23 | 11/30/23 | Approved | Thoracic Spine CT |
2023-LHCC-759 | Thoracic Spine MRI | 10/16/23 | 11/30/23 | Approved | Thoracic Spine MRI |
2023-LHCC-763 | Unlisted Studies | 10/16/23 | 11/30/23 | Approved | Unlisted Studies |
2023-LHCC-764 | Upper Extremity CT (Hand, Wrist, Long bone, or Shoulder CT) | 10/16/23 | 11/30/23 | Approved | Upper Extremity CT (Hand, Wrist, Long bone, or Shoulder CT) |
2023-LHCC-765 | Upper Extremity CT Angiography | 10/16/23 | 11/30/23 | Approved | Upper Extremity CT Angiography |
2023-LHCC-766 | Upper Extremity MRA/MRV | 10/16/23 | 11/30/23 | Approved | Upper Extremity MRA/MRV |
2023-LHCC-767 | Upper Extremity MRI (Hand, Wrist, Elbow, Long bone, or Shoulder MRI) | 10/16/23 | 11/30/23 | Approved | Upper Extremity MRI (Hand, Wrist, Elbow, Long bone, or Shoulder MRI) |
2023-LHCC-718 | Chest (Thorax) MRI | 10/16/23 | 11/30/23 | Approved | Chest (Thorax) MRI |
2023-LHCC-719 | Chest CTA | 10/16/23 | 11/30/23 | Approved | Chest CTA |
2023-LHCC-720 | Chest MRA | 10/16/23 | 11/30/23 | Approved | Chest MRA |
2023-LHCC-721 | CT (Virtual) Colonoscopy -1 | 10/16/23 | 11/30/23 | Approved | CT (Virtual) Colonoscopy -1 |
2023-LHCC-722 | CT (Virtual) Colonoscopy -2 | 10/16/23 | 11/30/23 | Approved | CT (Virtual) Colonoscopy -2 |
2023-LHCC-723 | CT Bone Density Study | 10/16/23 | 11/30/23 | Approved | CT Bone Density Study |
2023-LHCC-726 | Coronary Artery Calcium Scoring by: EBCT or Non-Contrast CCT | 10/16/23 | 11/30/23 | Approved | Coronary Artery Calcium Scoring by: EBCT or Non-Contrast CCT |
2023-LHCC-727 | Fetal MRI | 10/16/23 | 11/30/23 | Approved | Fetal MRI |
2023-LHCC-728 | Functional Brain MRI | 10/16/23 | 11/30/23 | Approved | Functional Brain MRI |
2023-LHCC-729 | CT Heart CT heart Congenital | 10/16/23 | 11/30/23 | Approved | CT Heart CT heart Congenital |
2023-LHCC-730 | Heart MRI | 10/16/23 | 11/30/23 | Approved | Heart MRI |
2023-LHCC-735 | Low Dose CT for Lung Cancer Screening | 10/16/23 | 11/30/23 | Approved | Low Dose CT for Lung Cancer Screening |
2023-LHCC-736 | Lower Extremity CT (foot, ankle, leg or hip CT) | 10/16/23 | 11/30/23 | Approved | Lower Extremity CT (foot, ankle, leg or hip CT) |
2023-LHCC-737 | Lower Extremity CT Angiography | 10/16/23 | 11/30/23 | Approved | Lower Extremity CT Angiography |
2023-LHCC-738 | Lower Extremity MRA/MRV | 10/16/23 | 11/30/23 | Approved | Lower Extremity MRA/MRV |
2023-LHCC-739 | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) | 10/16/23 | 11/30/23 | Approved | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) |
2023-LHCC-740 | Lumbar Spine CT | 10/16/23 | 11/30/23 | Approved | Lumbar Spine CT |
2023-LHCC-741 | Lumbar Spine MRI | 10/16/23 | 11/30/23 | Approved | Lumbar Spine MRI |
2023-LHCC-742 | Myocardial Perfusion Imaging (Nuclear Cardiac Imaging Study) | 10/16/23 | 11/30/23 | Approved | Myocardial Perfusion Imaging (Nuclear Cardiac Imaging Study) |
2023-LHCC-744 | MUGA (Multiple Gated Acquisition) Scan | 10/16/23 | 11/30/23 | Approved | MUGA (Multiple Gated Acquisition) Scan |
2023-LHCC-695 | Abdomen CT | 10/13/23 | 11/27/23 | Approved | Abdomen CT |
2023-LHCC-696 | Abdomen CT Angiography | 10/13/23 | 11/27/23 | Approved | Abdomen CT Angiography |
2023-LHCC-697 | Abdomen MRA (Angiography) | 10/13/23 | 11/27/23 | Approved | Abdomen MRA (Angiography) |
2023-LHCC-698 | Abdomen MRI | 10/13/23 | 11/27/23 | Approved | Abdomen MRI |
2023-LHCC-699 | Abdomen/Pelvis CT Combo | 10/13/23 | 11/27/23 | Approved | Abdomen/Pelvis CT Combo |
2023-LHCC-700 | Abdomen/Pelvis CTA | 10/13/23 | 11/27/23 | Approved | Abdomen/Pelvis CTA |
2023-LHCC-701 | CTA Aortogram with Runoff | 10/13/23 | 11/27/23 | Approved | CTA Aortogram with Runoff |
2023-LHCC-703 | Bone Marrow MRI | 10/13/23 | 11/27/23 | Approved | Bone Marrow MRI |
2023-LHCC-704 | Brain (Head) CT | 10/13/23 | 11/27/23 | Approved | Brain (Head) CT |
2023-LHCC-705 | Brain (Head) CTA | 10/13/23 | 11/27/23 | Approved | Brain (Head) CTA |
2023-LHCC-706 | Brain (Head) MRA/MRV | 10/13/23 | 11/27/23 | Approved | Brain (Head) MRA/MRV |
2023-LHCC-707 | Brain (Head) MRI/Brain (Head) MRI w Internal Auditory Canal | 10/13/23 | 11/27/23 | Approved | Brain (Head) MRI/Brain (Head) MRI w Internal Auditory Canal |
2023-LHCC-708 | Brain (Head) MRS | 10/13/23 | 11/27/23 | Approved | Brain (Head) MRS |
2023-LHCC-709 | Brain PET Scan | 10/13/23 | 11/27/23 | Approved | Brain PET Scan |
2023-LHCC-711 | Breast MRI | 10/13/23 | 11/27/23 | Approved | Breast MRI |
2023-LHCC-712 | CT Coronary Angiography (CCTA) | 10/13/23 | 11/27/23 | Approved | CT Coronary Angiography (CCTA) |
2023-LHCC-713 | Cerebral Perfusion CT | 10/13/23 | 11/27/23 | Approved | Cerebral Perfusion CT |
2023-LHCC-715 | Cervical Spine CT | 10/13/23 | 11/27/23 | Approved | Cervical Spine CT |
2023-LHCC-716 | Cervical Spine MRI | 10/13/23 | 11/27/23 | Approved | Cervical Spine MRI |
2023-LHCC-717 | Chest (Thorax) CT | 10/13/23 | 11/27/23 | Approved | Chest (Thorax) CT |
2023-LHCC-1753 | Implantable Infusion Pump Insertion | 10/11/23 | 11/25/23 | Approved | Implantable Infusion Pump Insertion |
2023-LHCC-1754 | Epidural Spine Injection Trial Intrathecal Hybrid | 10/11/23 | 11/25/23 | Approved | Epidural Spine Injection Trial Intrathecal Hybrid |
2023-LHCC-1755 | Paravertebral Facet Joint injections or blocks | 10/11/23 | 11/25/23 | Approved | Paravertebral Facet Joint injections or blocks |
2023-LHCC-1889 | Shoulder Arthroscopy | 10/11/23 | 11/25/23 | Approved | Shoulder Arthroscopy |
2023-LHCC-2231 | Concert Genetics Gastroenterologic Disorders non-cancerous | 10/11/23 | 11/25/23 | Approved | Concert Genetics Gastroenterologic Disorders non-cancerous |
2023-LHCC-2232 | Concert Genetics General Approach to Genetic Testing | 10/11/23 | 11/25/23 | Approved | Concert Genetics General Approach to Genetic Testing |
2023-LHCC-2233 | Concert Genetics Hearing Loss | 10/11/23 | 11/25/23 | Approved | Concert Genetics Hearing Loss |
2023-LHCC-2234 | Concert Genetics Lung Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Lung Disorders |
2023-LHCC-2235 | Concert Genetics Kidney Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Kidney Disorders |
2023-LHCC-2236 | Concert Genetics Immune Autoimmune and Rheumatoid Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Immune Autoimmune and Rheumatoid Disorders |
2023-LHCC-2237 | Concert Genetics Hematologic Conditions non-cancerous | 10/11/23 | 11/25/23 | Approved | Concert Genetics Hematologic Conditions non-cancerous |
2023-LHCC-2238 | Concert Genetics Skeletal Dysplasia Rare Bone Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Skeletal Dysplasia Rare Bone Disorders |
2023-LHCC-2239 | Concert Genetics Oncology Cytogenetic Testing | 10/11/23 | 11/25/23 | Approved | Concert Genetics Oncology Cytogenetic Testing |
2023-LHCC-2240 | Concert Genetics Preimplantation Genetic Testing | 10/11/23 | 11/25/23 | Approved | Concert Genetics Preimplantation Genetic Testing |
2023-LHCC-2241 | Concert Genetics Oncology Cancer Screening | 10/11/23 | 11/25/23 | Approved | Concert Genetics Oncology Cancer Screening |
2023-LHCC-2242 | Concert Genetics Prenatal and Preconception Carrier Screening | 10/11/23 | 11/25/23 | Approved | Concert Genetics Prenatal and Preconception Carrier Screening |
2023-LHCC-2243 | Concert Genetics Non-invasive Prenatal Screening | 10/11/23 | 11/25/23 | Approved | Concert Genetics Non-invasive Prenatal Screening |
2023-LHCC-2244 | Concert Genetics Prenatal Diagnosis Pregnancy Loss | 10/11/23 | 11/25/23 | Approved | Concert Genetics Prenatal Diagnosis Pregnancy Loss |
2023-LHCC-2245 | Concert Genetics Multi-system Inherited Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Multi-system Inherited Disorders |
2023-LHCC-2246 | Concert Genetics Metabolic Endocrine Mitochondrial Disorder | 10/11/23 | 11/25/23 | Approved | Concert Genetics Metabolic Endocrine Mitochondrial Disorder |
2023-LHCC-1703 | Pediatric Kidney Transplant | 10/11/23 | 11/25/23 | Approved | Pediatric Kidney Transplant |
2023-LHCC-1745 | Donor Lymphocyte Infusion | 10/11/23 | 11/25/23 | Approved | Donor Lymphocyte Infusion |
2023-LHCC-1838 | Intensity-Modulated Radiotherapy | 10/11/23 | 11/25/23 | Approved | Intensity-Modulated Radiotherapy |
2023-LHCC-1882 | Knee Arthroplasty | 10/11/23 | 11/25/23 | Approved | Knee Arthroplasty |
2023-LHCC-1883 | Lumbar Artificial Disc Replacement | 10/11/23 | 11/25/23 | Approved | Lumbar Artificial Disc Replacement |
2023-LHCC-1884 | Lumbar Spine Surgery | 10/11/23 | 11/25/23 | Approved | Lumbar Spine Surgery |
2023-LHCC-1885 | Knee Arthroscopy | 10/11/23 | 11/25/23 | Approved | Knee Arthroscopy |
2023-LHCC-1886 | Sacroiliac Joint Infusion | 10/11/23 | 11/25/23 | Approved | Sacroiliac Joint Infusion |
2023-LHCC-1887 | Shoulder Arthroplasty | 10/11/23 | 11/25/23 | Approved | Shoulder Arthroplasty |
2023-LHCC-1906 | Facility-Based Sleep Studies for OSA | 10/11/23 | 11/25/23 | Approved | Facility-Based Sleep Studies for OSA |
2023-HUM-2199 | Air Ambulance policy | 10/11/23 | 11/25/23 | Approved | Air Ambulance policy |
2023-ACLA-2221 | Provider Quality Monitoring Strategy | 10/11/23 | 11/25/23 | Approved | Provider Quality Monitoring Strategy |
2023-UHC-2222 | Provider Quality Monitoring Strategy | 10/11/23 | 11/25/23 | Approved | Provider Quality Monitoring Strategy |
2023-HUM-2224 | Provider Quality Monitoring Strategy | 10/11/23 | 11/25/23 | Approved | Provider Quality Monitoring Strategy |
2023-LHCC-2225 | Lantidra (donislecel) Allogeneic Pancreatic Islet Cellular Therapy | 10/11/23 | 11/25/23 | Approved | Lantidra (donislecel) Allogeneic Pancreatic Islet Cellular Therapy |
2023-LHCC-2226 | Concert Genetics Aortopathies and Connective Tissue Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Aortopathies and Connective Tissue Disorders |
2023-LHCC-2227 | Concert Genetics Cardiac Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Cardiac Disorders |
2023-LHCC-2228 | Concert Genetics Eye Disorders | 10/11/23 | 11/25/23 | Approved | Concert Genetics Eye Disorders |
2023-LHCC-2229 | Concert Genetics Dermatologic Conditions | 10/11/23 | 11/25/23 | Approved | Concert Genetics Dermatologic Conditions |
2023-LHCC-2230 | Concert Genetics Epilepsy Neurodegenerative and Neuromuscular Conditions | 10/11/23 | 11/25/23 | Approved | Concert Genetics Epilepsy Neurodegenerative and Neuromuscular Conditions |
2023-UHC-486 | Abnormal Uterine Bleeding and Uterine Fibroids | 10/11/23 | 11/25/23 | Approved | Abnormal Uterine Bleeding and Uterine Fibroids |
2023-UHC-562 | Balloon Sinus Ostial Dilation | 10/11/23 | 11/25/23 | Approved | Balloon Sinus Ostial Dilation |
2023-UHC-788 | Mechanical Stretching Devices | 10/11/23 | 11/25/23 | Approved | Mechanical Stretching Devices |
2023-UHC-790 | Nerve Graft to restore Erectile Function during Radical Prostatectomy | 10/11/23 | 11/25/23 | Approved | Nerve Graft to restore Erectile Function during Radical Prostatectomy |
2023-LHCC-934 | Behavioral Health Provider Quality Program | 10/11/23 | 11/25/23 | Approved | Behavioral Health Provider Quality Program |
2023-LHCC-1109 | Diaphragmatic/Phrenic Nerve Stimulation | 10/11/23 | 11/25/23 | Approved | Diaphragmatic/Phrenic Nerve Stimulation |
2023-LHCC-1228 | Sacroiliac Joint Interventions for Pain Management | 10/11/23 | 11/25/23 | Approved | Sacroiliac Joint Interventions for Pain Management |
2023-LHCC-1265 | Vagus Nerve Stimulation | 10/11/23 | 11/25/23 | Approved | Vagus Nerve Stimulation |
2023-LHCC-1269 | Gender Affirming Procedures | 10/11/23 | 11/25/23 | Approved | Gender Affirming Procedures |
2023-LHCC-1274 | Osteogenic Stimulation | 10/11/23 | 11/25/23 | Approved | Osteogenic Stimulation |
2023-LHCC-1356 | Lung Transplantation | 10/11/23 | 11/25/23 | Approved | Lung Transplantation |
2023-LHCC-1358 | Pancreas Transplantation | 10/11/23 | 11/25/23 | Approved | Pancreas Transplantation |
2023-LHCC-1411 | Medical Necessity Criteria | 10/11/23 | 11/25/23 | Approved | Medical Necessity Criteria |
2023-UHC-1423 | Total Artificial Heart and Ventricular Assist Devices | 10/11/23 | 11/25/23 | Approved | Total Artificial Heart and Ventricular Assist Devices |
2023-UHC-1425 | Neuropsychological Testing under the Medical Benefit | 10/11/23 | 11/25/23 | Approved | Neuropsychological Testing under the Medical Benefit |
2023-HUM-1428 | Preauthorization and Notification List | 10/11/23 | 11/25/23 | Completed | Preauthorization and Notification List |
2023-LHCC-1524 | Posterior Tibial Nerve Stimulation for Voiding Dysfunction | 10/11/23 | 11/25/23 | Approved | Posterior Tibial Nerve Stimulation for Voiding Dysfunction |
2023-LHCC-1525 | Intradiscal Steroid Injections for Pain Management | 10/11/23 | 11/25/23 | Approved | Intradiscal Steroid Injections for Pain Management |
2023-LHCC-1526 | Trigger Point Injections | 10/11/23 | 11/25/23 | Approved | Trigger Point Injections |
2023-LHCC-1527 | Nerve Blocks and Neurolysis for Pain Management | 10/11/23 | 11/25/23 | Approved | Nerve Blocks and Neurolysis for Pain Management |
2023-HBL-2263 | Claims Interest Policy | 11/9/23 | 12/24/23 | Under LDH Review | Claims Interest Policy |
2023-HBL-98 | Claim Submission: Required Information for Facilities | 9/19/23 | 11/3/23 | Approved | Claim Submission: Required Information for Facilities |
2023-UHC-215 | Spinal Fusion and Bone Healing Enhancement Products | 9/19/23 | 11/3/23 | Approved | Spinal Fusion and Bone Healing Enhancement Products |
2023-LHCC-1416 | Transportation Policy | 9/19/23 | 11/3/23 | Approved | Transportation Policy |
2023-HUM-1606 | Louisiana UM Program Description | 9/19/23 | 11/3/23 | Completed | Louisiana UM Program Description |
2023-HBL-2220 | Provider Digital Correspondence Initiative | 9/19/23 | 11/3/23 | Pending | Provider Digital Correspondence Initiative |
2023-LHCC-329 | Adverse Determinations | 9/18/23 | 11/2/23 | Completed | Adverse Determinations |
2023-LHCC-532 | Appropriate UM Professionals | 9/18/23 | 11/2/23 | Completed | Appropriate UM Professionals |
2023-LHCC-991 | Concurrent Review | 9/18/23 | 11/2/23 | Completed | Concurrent Review |
2023-UHC-1761 | Home Health | 9/18/23 | 11/2/23 | Approved | Home Health |
2023-HBL-1778 | Outpatient Glycated Hemoglobin and Protein Testing | 9/18/23 | 11/2/23 | Approved | Outpatient Glycated Hemoglobin and Protein Testing |
2023-HBL-1783 | Mechanical Embolectomy for Treatment of Stroke | 9/18/23 | 11/2/23 | Approved | Mechanical Embolectomy for Treatment of Stroke |
2023-HUM-2210 | J7300 - prevention of pregnancy | 9/18/23 | 11/2/23 | Approved | J7300 - prevention of pregnancy |
2023-HUM-2211 | G0480 & G0481 Limit Definitive Drug Testing to 12 Per Year | 9/18/23 | 11/2/23 | Approved | G0480 & G0481 Limit Definitive Drug Testing to 12 Per Year |
2023-HBL-2215 | Gamma Glutamyl Transferase Testing | 9/18/23 | 11/2/23 | Approved | Gamma Glutamyl Transferase Testing |
2023-HBL-2216 | Outpatient Laboratory-based Blood Glucose Testing | 9/18/23 | 11/2/23 | Approved | Outpatient Laboratory-based Blood Glucose Testing |
2023-HBL-2217 | Cryopreservation of Oocytes or Ovarian Tissue | 9/18/23 | 11/2/23 | Approved | Cryopreservation of Oocytes or Ovarian Tissue |
2023-HBL-2218 | Dynamic Low-Load Prolonged-Duration Stretch Devices | 9/18/23 | 11/2/23 | Approved | Dynamic Low-Load Prolonged-Duration Stretch Devices |
Medicaid Managed Care Policies & Procedures Archive (2023)
"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.
Below are items previously posted for public comment: